Celebrate with us

Chemaxon’s 25th anniversary User Group Meeting is happening in Boston, October 4, 2023. Presentations by expert guests, hands-on demos in our Tech Corner, and networking with your peers at the gala dinner with cake!

HubSpot Video

Details

 

ABP-CMX-23-2

When? 

October 4th, 2023
10 AM

With presentations and product demos throughout the day, culminating in a celebratory birthday dinner in the evening.

1241_02_frank-ockert-1498x1000

Where? 

Artists For Humanity EpiCenter,
100 W, 2nd street, Boston, MA 02127

We believe in giving back and are proud to host you at a venue dedicated to providing paid work opportunities for underprivileged youth in Boston.

 

Speakers

Understanding the evolving needs of early drug discovery

Over the years, we have been dedicated to empowering scientists in their research efforts. We value the trust of the scientific community, and are proud to host a day filled with thought-provoking discussions about our shared passion.

Meet our guest speakers:

joe_michel_head_shot@72x

Joe Michel 

Director of Informatics, Cytokinetics

Generative AI Begins to Dominate the AI Conversation in Early Drug Discovery
-
Joe will focus on how deep neural networks and generative AI are transforming molecular design, improving predictions, and enhancing the drug discovery process.

 

JohnMcNeilHeadshot2@72x (1)

John McNeil 

Life Science R&D Informatics Strategist

Project team data visualization and decision support solutions - Core requirements and must-have features
-
John will talk about the core requirements and must-have features of collaborative data visualization and decision support solutions in the DMTA cycle.

 

Zofia Jordan-latest

Zofia Jordan

Compound Compliance Consultant, formerly of GSK

Advocating Change: One Synthetic Cannabinoid at a Time

-

Zofia will talk about how compliance aspects associated with sample management are becoming more critical due to the collaborative and globally distributed nature of research. She will showcase it through her experience working with the industry and authorities to modify the Third Generation Synthetic Cannabinoids amendment.

David_Klatte

David Klatte

Senior Director, Scientific Solution Engineering, Pfizer

ChemistryView: how Pfizer simplifies its legacy desktop chemistry systems

-

David will introduce ChemistryView, Pfizer’s custom developed Java component designed to simplify  their legacy chemistry software systems. ChemistryView stemmed from a strong desire for the company’s often 20-years old applications to be user customizable and to have consistent tools for managing advanced stereochemistry.

Gerd_Blanke_Mask (1)

Gerd Blanke

Technical director, StructurePendium Technologies GmbH

Are reaction data FAIR … and what can we do with that?

-

Gerd will talk about how chemical reaction data needs to comply with FAIR principles in order to be reliable, reproductible, and be used for accurate AI/ML predictions. He will address the specific challenges related to in-house chemical reaction data capturing and discuss what steps should be taken to make these databases more consistent for precise predictions.

Adrien

Adrian Stevens

Chief Product Officer, Chemaxon

Helping our customers work into the future

-

With 25 years of cheminformatics innovation at Chemaxon, we have made it our business to help scientists engaged in therapeutic research to draw, define and find their chemical compounds, both reliably and with ease. In this talk, Adrian will explore some of the emerging trends and challenges that our customers are now facing and how we can help. He will showcase upcoming technologies and tools that will help our customers continue to work into the future.

Register for the event

Agenda

Program details:

 

Block Title Presenter
Registration
9:30:00
   
CXN Session
10:00 - 10:50
Opening remarks Richard Jones, CEO, Chemaxon
Helping our customers work into the future Adrian Stevens, CPO, Chemaxon
Morning Session
10:50 - 14:00
Generative AI Begins to Dominate the AI Conversation in Early Drug Discovery Joe Michel, Director of Informatics, Cytokinetics
COFFEE BREAK + TECH CORNER
ChemistryView: how Pfizer simplifies its legacy desktop chemistry systems David Klatte, Senior Director of Scientific Solution Engineering, Pfizer
Challenges and Opportunities for AI in drug discovery Pat Walters, Chief Data Officer, Relay Therapeutics
LUNCH + NETWORKING + TECH CORNER
Afternoon Session
14:00 - 17:30
Panel discussion on the use of AI in drug discovery - moderated by Jan Christopherson, Application Scientist, Chemaxon Joe Michel, Pat Walters, Dr. Arun Subramaniyan, Adrian Stevens
Advocating Change: One Synthetic Cannabinoid at a Time Zofia Jordan, Compound Complance Consultant, formerly of GSK
COFFEE BREAK + TECH CORNER
Project team data visualization and decision support solutions: core requirements and must-have features John McNeil, Life Sciences R&D Informatics Strategist
Are reaction data FAIR … and what can we do with that? Gerd Blanke, Chem- and bioinformatics Consultant
The World’s Largest Protein-Ligand Complex and Binding Affinity Dataset for Data Driven Methods in Drug Design Dr. Arun Subramaniyan, VP Cloud & AI Strategy and Execution, Intel
Closing Remarks Richard Jones, CEO, Chemaxon
Evening session
17:30 -
EVENING SOCIAL
GALA DINNER
Privacy policy and consent declaration of the event